Vaccine Market To Hit $19.2B by 2010

"United States represents the largest market for human vaccines with sales estimated at US$6.9 billion for 2007. Within Europe, France, Germany, and United Kingdom together account for more than 3/4th of the market. In Japan, Pediatric prophylactic vaccines sales are likely to grow at a compounded annual rate of 9.9% over the period 2005-2010. Human vaccines market in Asia-Pacific is projected to reach US$1.3 billion by the year 2010. Most multinational companies engaged in vaccine production are based in the US and Europe.....Pediatric combination vaccines, another new entrant in the vaccines market are forecast to fuel growth in the coming years. The market is expected to witness new levels with adoption of novel vaccine delivery mechanisms such as edible, oral, and mucosal. Also critical to market success is the need for using improved adjuvants in vaccines for optimal immunogenicity.....Dominant players in the market comprise leading pharmaceutical companies including Sanofi-Aventis, GlaxoSmithKline, Wyeth, and Merck. These companies together command about 80% share of the global human vaccines market." - Global Industry Analysts, Inc.

Barbara Loe Fisher Commentary:

If anyone doubts why drug companies making and selling vaccines are lobbying so hard to convince California legislators to pass a precedent-setting law that would automatically mandate every new vaccine the CDC recommends for "universal use" by all children, the recent market analysis by Global Industry Analysts gives the answer: forcing vaccine use is a multi-billion dollar business. The U.S. is the largest market for human vaccines: vaccine manufacturers will rake in $6.9B in 2007. Much of the profit is guaranteed because the lobbying alliance between drug companies, public health officials and pediatricians that has formed during the past quarter century has worked hard to convince politicians to mandate the use of more vaccines by US citizens than are used by any other country in the world.

The freedom to exercise informed consent to vaccination and make informed voluntary vaccine choices in the US is being eroded by clueless legislators listening to profit-seeking drug companies and zealous government health officials in search of a 100 percent vaccination rate. No question that forced use of multiple vaccines makes for good profits. But where is the science that demonstrates it leads to good health?

The worldwide human vaccines market is projected to reach $19.2B and it is no surprise that "therapeutic" vaccines are projected to be the fastest growing segment with $3.3B projected sales by 2010 in the U.S. alone. The therapeutic vaccine market includes people suffering with chronic brain and immune system dysfunction, the very kinds of chronic diseases and disorders that can be caused by prophylactic vaccine use. In other words, those children who are harmed by forced prophylactic vaccine use will become consumers of therapeutic vaccines.

The price we will pay for having placed blind trust in physicians in industry and government, who are promoting mass, mandatory use of multiple vaccines, will be far higher in the future.

2 comments:

Anonymous said...

if you work in public health these days and you point out some of these things Barbbara, you get canned!

I know it happened to me

David N. Brown (davidbrown@openpagepublishing.com) said...

I am an autistic adult, interested in DEBUNKING claims about vaccines causing autism. With regards to the supposed profitability of vaccines, all you have really shown is that the GROSS sales of all vaccines combined is less than what what one of the major manufacturers can earn from its total product line. Since vaccine prices are effectively controlled by the government,it is intuitively obvious that relatively little money from sales translates into profit.